News and Announcements
Actinogen Medical US Roadshow Investor Presentation July 2016
- Published July 15, 2016 12:03PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
15th July 2016, ASX Announcement
Focusing on an innovative approach, through the inhibition of cortisol production, for treating cognitive impairment in chronic neurodegenerative and metabolic diseases
Xanamem™: A prime investment opportunity
- Alzheimer’s – a significant unmet need in a huge and growing global market
- Xanamem™’s innovative, differentiated mechanism of action targeting the stress hormone cortisol
- Evidence Xanamem™ is both symptomatic and disease modifying
- Phase II study funded through to completion
- Patent protected to 2031 – composition of matter
- Value enhancing additional indications in substantive markets of interest to big pharmaceutical companies – Alzheimers disease, Diabetes, Parkinson’s disease
To view the full announcement, please click on the button below.
Company Updates
Cameron Blanks CEO Interview
In this Executive interview, Cameron Blanks of Pacific Equity Partners (PEP) shares how the PEP Gateway program is democratising private equity investments. Learn about the exceptional growth of private markets, the outperformance compared to public markets, and the steps PEP takes to ensure diversified and risk-managed portfolios. Watch the interview to gain valuable insights into […]
Aaron Trevis CEO Interview
Explore the future of surfing with Aaron Trevis, Founder & CEO of Surf Lakes, as he shares insights on their groundbreaking artificial wave technology and ambitious global expansion plans. Find out how Surf Lakes is positioned to tap into the vast market potential and bring perfect waves to surfing enthusiasts worldwide.
Mark Avery CEO Interview
Join Mark Avery, founder of Bell Resources, as he discusses the company’s unique business model that combines EV charging with other essential services. Learn how Bell Resources plans to address Australia’s infrastructure gap and capitalise on the growing EV market with innovative technology and strategic expansion.
Backed By Leading Investment Groups and Family Offices
